nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Ursodeoxycholic acid—primary biliary cirrhosis	0.447	0.748	CbGbCtD
Bosentan—ABCB11—bile canaliculus—primary biliary cirrhosis	0.0806	0.622	CbGeAlD
Bosentan—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0634	0.106	CbGbCtD
Bosentan—CYP2C9—Colchicine—primary biliary cirrhosis	0.0552	0.0924	CbGbCtD
Bosentan—CYP3A4—Colchicine—primary biliary cirrhosis	0.0321	0.0537	CbGbCtD
Bosentan—ABCB11—bile duct—primary biliary cirrhosis	0.0252	0.194	CbGeAlD
Bosentan—ABCB11—bile—primary biliary cirrhosis	0.0193	0.149	CbGeAlD
Bosentan—ABCB11—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.011	0.15	CbGpPWpGaD
Bosentan—ABCB11—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00832	0.114	CbGpPWpGaD
Bosentan—ABCB11—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.00349	0.0478	CbGpPWpGaD
Bosentan—ABCB11—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00251	0.0344	CbGpPWpGaD
Bosentan—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00242	0.0331	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00219	0.03	CbGpPWpGaD
Bosentan—EDNRB—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.00213	0.0292	CbGpPWpGaD
Bosentan—EDNRB—liver—primary biliary cirrhosis	0.00195	0.0151	CbGeAlD
Bosentan—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00183	0.0251	CbGpPWpGaD
Bosentan—ABCB11—liver—primary biliary cirrhosis	0.00157	0.0122	CbGeAlD
Bosentan—EDNRA—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.00153	0.0209	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.00144	0.0197	CbGpPWpGaD
Bosentan—Skin discolouration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00681	CcSEcCtD
Bosentan—Bone disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00681	CcSEcCtD
Bosentan—Skin discolouration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00681	CcSEcCtD
Bosentan—Bone disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00681	CcSEcCtD
Bosentan—Blood bilirubin increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0013	0.00651	CcSEcCtD
Bosentan—Blood bilirubin increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0013	0.00651	CcSEcCtD
Bosentan—ABCB11—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.00128	0.0175	CbGpPWpGaD
Bosentan—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00623	CcSEcCtD
Bosentan—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00623	CcSEcCtD
Bosentan—Bladder pain—Colchicine—primary biliary cirrhosis	0.00124	0.00619	CcSEcCtD
Bosentan—Cystitis noninfective—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00601	CcSEcCtD
Bosentan—Cystitis noninfective—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00601	CcSEcCtD
Bosentan—Influenza like illness—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00598	CcSEcCtD
Bosentan—Influenza like illness—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00598	CcSEcCtD
Bosentan—Cystitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00119	0.00594	CcSEcCtD
Bosentan—Cystitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00119	0.00594	CcSEcCtD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00118	0.0161	CbGpPWpGaD
Bosentan—Fluid retention—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00584	CcSEcCtD
Bosentan—Fluid retention—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00584	CcSEcCtD
Bosentan—Hepatic function abnormal—Colchicine—primary biliary cirrhosis	0.00114	0.00569	CcSEcCtD
Bosentan—Bladder pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00556	CcSEcCtD
Bosentan—Bladder pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00556	CcSEcCtD
Bosentan—Ecchymosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00556	CcSEcCtD
Bosentan—Ecchymosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00556	CcSEcCtD
Bosentan—Blood alkaline phosphatase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00514	CcSEcCtD
Bosentan—Blood alkaline phosphatase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00514	CcSEcCtD
Bosentan—Hepatic function abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00511	CcSEcCtD
Bosentan—Hepatic function abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00511	CcSEcCtD
Bosentan—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00101	0.0138	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.001	0.0137	CbGpPWpGaD
Bosentan—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000944	0.00471	CcSEcCtD
Bosentan—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000944	0.00471	CcSEcCtD
Bosentan—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00094	0.00469	CcSEcCtD
Bosentan—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00094	0.00469	CcSEcCtD
Bosentan—Dehydration—Colchicine—primary biliary cirrhosis	0.000925	0.00462	CcSEcCtD
Bosentan—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000916	0.00458	CcSEcCtD
Bosentan—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000916	0.00458	CcSEcCtD
Bosentan—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.000912	0.00456	CcSEcCtD
Bosentan—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.000912	0.00456	CcSEcCtD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.00091	0.0125	CbGpPWpGaD
Bosentan—Cramp muscle—Colchicine—primary biliary cirrhosis	0.000896	0.00448	CcSEcCtD
Bosentan—ABCB11—Recycling of bile acids and salts—ALB—primary biliary cirrhosis	0.000874	0.012	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000842	0.0115	CbGpPWpGaD
Bosentan—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.000832	0.00415	CcSEcCtD
Bosentan—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.000832	0.00415	CcSEcCtD
Bosentan—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000825	0.00412	CcSEcCtD
Bosentan—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000825	0.00412	CcSEcCtD
Bosentan—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000817	0.00408	CcSEcCtD
Bosentan—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.000817	0.00408	CcSEcCtD
Bosentan—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.000817	0.00408	CcSEcCtD
Bosentan—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000817	0.00408	CcSEcCtD
Bosentan—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.000805	0.00402	CcSEcCtD
Bosentan—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.000805	0.00402	CcSEcCtD
Bosentan—Neutropenia—Colchicine—primary biliary cirrhosis	0.000804	0.00402	CcSEcCtD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000785	0.0107	CbGpPWpGaD
Bosentan—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.000773	0.00386	CcSEcCtD
Bosentan—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.000773	0.00386	CcSEcCtD
Bosentan—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.000773	0.00386	CcSEcCtD
Bosentan—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.000773	0.00386	CcSEcCtD
Bosentan—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.000769	0.0105	CbGpPWpGaD
Bosentan—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.000753	0.00376	CcSEcCtD
Bosentan—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.000753	0.00376	CcSEcCtD
Bosentan—Stomatitis—Colchicine—primary biliary cirrhosis	0.000748	0.00373	CcSEcCtD
Bosentan—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000743	0.00371	CcSEcCtD
Bosentan—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000743	0.00371	CcSEcCtD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000732	0.01	CbGpPWpGaD
Bosentan—Haematuria—Colchicine—primary biliary cirrhosis	0.000731	0.00365	CcSEcCtD
Bosentan—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000723	0.00361	CcSEcCtD
Bosentan—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000723	0.00361	CcSEcCtD
Bosentan—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000718	0.00359	CcSEcCtD
Bosentan—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000718	0.00359	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.000717	0.00982	CbGpPWpGaD
Bosentan—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000714	0.00357	CcSEcCtD
Bosentan—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000714	0.00357	CcSEcCtD
Bosentan—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000703	0.00351	CcSEcCtD
Bosentan—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000703	0.00351	CcSEcCtD
Bosentan—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000699	0.00349	CcSEcCtD
Bosentan—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000699	0.00349	CcSEcCtD
Bosentan—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000693	0.00346	CcSEcCtD
Bosentan—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000693	0.00346	CcSEcCtD
Bosentan—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000689	0.00344	CcSEcCtD
Bosentan—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000689	0.00344	CcSEcCtD
Bosentan—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000689	0.00344	CcSEcCtD
Bosentan—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000689	0.00344	CcSEcCtD
Bosentan—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.000685	0.00342	CcSEcCtD
Bosentan—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000679	0.00339	CcSEcCtD
Bosentan—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000679	0.00339	CcSEcCtD
Bosentan—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000677	0.00338	CcSEcCtD
Bosentan—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000677	0.00338	CcSEcCtD
Bosentan—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000675	0.00337	CcSEcCtD
Bosentan—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000675	0.00337	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000672	0.0092	CbGpPWpGaD
Bosentan—Jaundice—Ursodeoxycholic acid—primary biliary cirrhosis	0.000672	0.00336	CcSEcCtD
Bosentan—Jaundice—Chenodeoxycholic acid—primary biliary cirrhosis	0.000672	0.00336	CcSEcCtD
Bosentan—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00067	0.00335	CcSEcCtD
Bosentan—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00067	0.00335	CcSEcCtD
Bosentan—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00067	0.00335	CcSEcCtD
Bosentan—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00067	0.00335	CcSEcCtD
Bosentan—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000657	0.00328	CcSEcCtD
Bosentan—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000657	0.00328	CcSEcCtD
Bosentan—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000652	0.00326	CcSEcCtD
Bosentan—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000652	0.00326	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.000651	0.00892	CbGpPWpGaD
Bosentan—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00065	0.00325	CcSEcCtD
Bosentan—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00065	0.00325	CcSEcCtD
Bosentan—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000646	0.00323	CcSEcCtD
Bosentan—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000646	0.00323	CcSEcCtD
Bosentan—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.000645	0.00884	CbGpPWpGaD
Bosentan—Eye disorder—Colchicine—primary biliary cirrhosis	0.000643	0.00321	CcSEcCtD
Bosentan—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000622	0.00311	CcSEcCtD
Bosentan—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000622	0.00311	CcSEcCtD
Bosentan—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00062	0.0031	CcSEcCtD
Bosentan—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000619	0.00309	CcSEcCtD
Bosentan—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000619	0.00309	CcSEcCtD
Bosentan—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000611	0.00305	CcSEcCtD
Bosentan—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000611	0.00305	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.00061	0.00836	CbGpPWpGaD
Bosentan—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000609	0.00304	CcSEcCtD
Bosentan—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000609	0.00304	CcSEcCtD
Bosentan—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000606	0.00303	CcSEcCtD
Bosentan—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000606	0.00303	CcSEcCtD
Bosentan—Malnutrition—Colchicine—primary biliary cirrhosis	0.000599	0.00299	CcSEcCtD
Bosentan—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000578	0.00289	CcSEcCtD
Bosentan—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000578	0.00289	CcSEcCtD
Bosentan—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00288	CcSEcCtD
Bosentan—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00288	CcSEcCtD
Bosentan—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000576	0.00288	CcSEcCtD
Bosentan—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00287	CcSEcCtD
Bosentan—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00287	CcSEcCtD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000562	0.00769	CbGpPWpGaD
Bosentan—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000561	0.0028	CcSEcCtD
Bosentan—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000561	0.0028	CcSEcCtD
Bosentan—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000559	0.00279	CcSEcCtD
Bosentan—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000559	0.00279	CcSEcCtD
Bosentan—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000557	0.00278	CcSEcCtD
Bosentan—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000557	0.00278	CcSEcCtD
Bosentan—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000555	0.00277	CcSEcCtD
Bosentan—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000555	0.00277	CcSEcCtD
Bosentan—Anaemia—Colchicine—primary biliary cirrhosis	0.000554	0.00277	CcSEcCtD
Bosentan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000553	0.00756	CbGpPWpGaD
Bosentan—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.000549	0.00751	CbGpPWpGaD
Bosentan—Angioedema—Colchicine—primary biliary cirrhosis	0.000548	0.00274	CcSEcCtD
Bosentan—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000538	0.00269	CcSEcCtD
Bosentan—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000538	0.00269	CcSEcCtD
Bosentan—Leukopenia—Colchicine—primary biliary cirrhosis	0.000536	0.00268	CcSEcCtD
Bosentan—CYP2C9—liver—primary biliary cirrhosis	0.000533	0.00412	CbGeAlD
Bosentan—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000531	0.00265	CcSEcCtD
Bosentan—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000531	0.00265	CcSEcCtD
Bosentan—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000521	0.0026	CcSEcCtD
Bosentan—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000521	0.0026	CcSEcCtD
Bosentan—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000518	0.00259	CcSEcCtD
Bosentan—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000518	0.00259	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000512	0.00701	CbGpPWpGaD
Bosentan—Arthralgia—Colchicine—primary biliary cirrhosis	0.00051	0.00255	CcSEcCtD
Bosentan—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000505	0.00691	CbGpPWpGaD
Bosentan—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000498	0.00249	CcSEcCtD
Bosentan—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000498	0.00249	CcSEcCtD
Bosentan—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000492	0.00246	CcSEcCtD
Bosentan—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000492	0.00246	CcSEcCtD
Bosentan—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000484	0.00242	CcSEcCtD
Bosentan—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000484	0.00242	CcSEcCtD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000483	0.00661	CbGpPWpGaD
Bosentan—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000483	0.00241	CcSEcCtD
Bosentan—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000483	0.00241	CcSEcCtD
Bosentan—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000482	0.00241	CcSEcCtD
Bosentan—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000482	0.00241	CcSEcCtD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000481	0.00659	CbGpPWpGaD
Bosentan—Shock—Colchicine—primary biliary cirrhosis	0.000481	0.0024	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000481	0.00659	CbGpPWpGaD
Bosentan—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00048	0.0024	CcSEcCtD
Bosentan—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000479	0.00239	CcSEcCtD
Bosentan—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.000476	0.00238	CcSEcCtD
Bosentan—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.000476	0.00238	CcSEcCtD
Bosentan—Skin disorder—Colchicine—primary biliary cirrhosis	0.000475	0.00237	CcSEcCtD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000474	0.00649	CbGpPWpGaD
Bosentan—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000473	0.00236	CcSEcCtD
Bosentan—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000473	0.00236	CcSEcCtD
Bosentan—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00047	0.00235	CcSEcCtD
Bosentan—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00047	0.00235	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000465	0.00636	CbGpPWpGaD
Bosentan—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000458	0.00229	CcSEcCtD
Bosentan—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000458	0.00229	CcSEcCtD
Bosentan—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000458	0.00229	CcSEcCtD
Bosentan—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000458	0.00229	CcSEcCtD
Bosentan—ABCB11—Bile acid and bile salt metabolism—ALB—primary biliary cirrhosis	0.000457	0.00626	CbGpPWpGaD
Bosentan—Hypotension—Colchicine—primary biliary cirrhosis	0.000457	0.00228	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000455	0.00227	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000455	0.00227	CcSEcCtD
Bosentan—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000453	0.00226	CcSEcCtD
Bosentan—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000453	0.00226	CcSEcCtD
Bosentan—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000453	0.00619	CbGpPWpGaD
Bosentan—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000448	0.00224	CcSEcCtD
Bosentan—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000448	0.00224	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000446	0.00223	CcSEcCtD
Bosentan—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000439	0.0022	CcSEcCtD
Bosentan—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000439	0.0022	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000437	0.00598	CbGpPWpGaD
Bosentan—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000437	0.00218	CcSEcCtD
Bosentan—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000437	0.00218	CcSEcCtD
Bosentan—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000432	0.00216	CcSEcCtD
Bosentan—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000432	0.00216	CcSEcCtD
Bosentan—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000431	0.00215	CcSEcCtD
Bosentan—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000431	0.00215	CcSEcCtD
Bosentan—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00043	0.00215	CcSEcCtD
Bosentan—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00043	0.00215	CcSEcCtD
Bosentan—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000429	0.00214	CcSEcCtD
Bosentan—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000429	0.00214	CcSEcCtD
Bosentan—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000427	0.00213	CcSEcCtD
Bosentan—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000427	0.00213	CcSEcCtD
Bosentan—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000425	0.00212	CcSEcCtD
Bosentan—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000425	0.00212	CcSEcCtD
Bosentan—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000425	0.00212	CcSEcCtD
Bosentan—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000422	0.00211	CcSEcCtD
Bosentan—Fatigue—Colchicine—primary biliary cirrhosis	0.000422	0.00211	CcSEcCtD
Bosentan—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000419	0.00209	CcSEcCtD
Bosentan—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000419	0.00209	CcSEcCtD
Bosentan—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000411	0.00205	CcSEcCtD
Bosentan—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000411	0.00205	CcSEcCtD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000408	0.00559	CbGpPWpGaD
Bosentan—CYP3A4—liver—primary biliary cirrhosis	0.000407	0.00314	CbGeAlD
Bosentan—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.0004	0.002	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.0004	0.002	CcSEcCtD
Bosentan—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.0004	0.002	CcSEcCtD
Bosentan—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000397	0.00199	CcSEcCtD
Bosentan—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000397	0.00199	CcSEcCtD
Bosentan—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000395	0.00197	CcSEcCtD
Bosentan—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000395	0.00197	CcSEcCtD
Bosentan—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000392	0.00196	CcSEcCtD
Bosentan—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000392	0.00196	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000392	0.00536	CbGpPWpGaD
Bosentan—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000391	0.00195	CcSEcCtD
Bosentan—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000391	0.00195	CcSEcCtD
Bosentan—Urticaria—Colchicine—primary biliary cirrhosis	0.000389	0.00194	CcSEcCtD
Bosentan—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000387	0.00193	CcSEcCtD
Bosentan—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000387	0.00193	CcSEcCtD
Bosentan—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000387	0.00193	CcSEcCtD
Bosentan—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000382	0.00191	CcSEcCtD
Bosentan—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000382	0.00191	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.00038	0.0052	CbGpPWpGaD
Bosentan—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000379	0.0019	CcSEcCtD
Bosentan—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000379	0.0019	CcSEcCtD
Bosentan—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000379	0.00189	CcSEcCtD
Bosentan—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000379	0.00189	CcSEcCtD
Bosentan—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000376	0.00188	CcSEcCtD
Bosentan—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000376	0.00188	CcSEcCtD
Bosentan—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000376	0.00188	CcSEcCtD
Bosentan—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000376	0.00188	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000366	0.00501	CbGpPWpGaD
Bosentan—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00036	0.0018	CcSEcCtD
Bosentan—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000359	0.0018	CcSEcCtD
Bosentan—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000359	0.0018	CcSEcCtD
Bosentan—Asthenia—Colchicine—primary biliary cirrhosis	0.000351	0.00175	CcSEcCtD
Bosentan—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00174	CcSEcCtD
Bosentan—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00174	CcSEcCtD
Bosentan—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00174	CcSEcCtD
Bosentan—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00174	CcSEcCtD
Bosentan—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00174	CcSEcCtD
Bosentan—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00174	CcSEcCtD
Bosentan—EDNRB—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000346	0.00473	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000341	0.00467	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000339	0.00464	CbGpPWpGaD
Bosentan—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000335	0.00167	CcSEcCtD
Bosentan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000333	0.00456	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000333	0.00455	CbGpPWpGaD
Bosentan—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000324	0.00162	CcSEcCtD
Bosentan—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000324	0.00162	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000318	0.00435	CbGpPWpGaD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000317	0.00434	CbGpPWpGaD
Bosentan—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000315	0.00432	CbGpPWpGaD
Bosentan—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000315	0.00158	CcSEcCtD
Bosentan—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000315	0.00158	CcSEcCtD
Bosentan—Vomiting—Colchicine—primary biliary cirrhosis	0.000311	0.00155	CcSEcCtD
Bosentan—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000311	0.00155	CcSEcCtD
Bosentan—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000311	0.00155	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000309	0.00423	CbGpPWpGaD
Bosentan—Rash—Colchicine—primary biliary cirrhosis	0.000308	0.00154	CcSEcCtD
Bosentan—Dermatitis—Colchicine—primary biliary cirrhosis	0.000308	0.00154	CcSEcCtD
Bosentan—Headache—Colchicine—primary biliary cirrhosis	0.000306	0.00153	CcSEcCtD
Bosentan—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000301	0.0015	CcSEcCtD
Bosentan—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000301	0.0015	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000292	0.004	CbGpPWpGaD
Bosentan—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00145	CcSEcCtD
Bosentan—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00145	CcSEcCtD
Bosentan—Nausea—Colchicine—primary biliary cirrhosis	0.000291	0.00145	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000289	0.00396	CbGpPWpGaD
Bosentan—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000281	0.00384	CbGpPWpGaD
Bosentan—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000281	0.00384	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.00028	0.00384	CbGpPWpGaD
Bosentan—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000279	0.0014	CcSEcCtD
Bosentan—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000279	0.0014	CcSEcCtD
Bosentan—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000277	0.00138	CcSEcCtD
Bosentan—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000277	0.00138	CcSEcCtD
Bosentan—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000277	0.00138	CcSEcCtD
Bosentan—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000277	0.00138	CcSEcCtD
Bosentan—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00138	CcSEcCtD
Bosentan—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00138	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000274	0.00375	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000263	0.0036	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000263	0.0036	CbGpPWpGaD
Bosentan—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000261	0.0013	CcSEcCtD
Bosentan—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000261	0.0013	CcSEcCtD
Bosentan—EDNRA—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000247	0.00339	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000244	0.00334	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000242	0.00331	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000239	0.00327	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000231	0.00316	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.00023	0.00315	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000229	0.00313	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000228	0.00311	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000221	0.00303	CbGpPWpGaD
Bosentan—CYP2C9—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000221	0.00302	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000208	0.00285	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000207	0.00283	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000196	0.00268	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000188	0.00257	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000188	0.00257	CbGpPWpGaD
Bosentan—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000185	0.00253	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000174	0.00239	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000173	0.00237	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000171	0.00234	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—LBR—primary biliary cirrhosis	0.000169	0.00232	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000165	0.00227	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000164	0.00224	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000161	0.00221	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000155	0.00212	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000149	0.00204	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000141	0.00193	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000137	0.00187	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.00013	0.00178	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000127	0.00174	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000125	0.00171	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000124	0.0017	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—OGDH—primary biliary cirrhosis	0.000122	0.00168	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000118	0.00161	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000115	0.00158	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000113	0.00155	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000111	0.00152	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.00011	0.00151	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PDHX—primary biliary cirrhosis	0.000109	0.00149	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000107	0.00146	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—DLAT—primary biliary cirrhosis	0.000103	0.0014	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ABCB4—primary biliary cirrhosis	0.000103	0.0014	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000101	0.00138	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AGT—primary biliary cirrhosis	9.85e-05	0.00135	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	9.79e-05	0.00134	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	9.44e-05	0.00129	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ELMO1—primary biliary cirrhosis	9.33e-05	0.00128	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AGT—primary biliary cirrhosis	8.95e-05	0.00122	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL10—primary biliary cirrhosis	8.89e-05	0.00122	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CCL5—primary biliary cirrhosis	8.43e-05	0.00115	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	8.4e-05	0.00115	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GGT1—primary biliary cirrhosis	8.21e-05	0.00112	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—MMP3—primary biliary cirrhosis	8.11e-05	0.00111	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	7.69e-05	0.00105	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL5—primary biliary cirrhosis	7.65e-05	0.00105	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.34e-05	0.001	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AGT—primary biliary cirrhosis	7.05e-05	0.000965	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP3—primary biliary cirrhosis	6.69e-05	0.000916	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—TYK2—primary biliary cirrhosis	6.69e-05	0.000916	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	6.55e-05	0.000896	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AGT—primary biliary cirrhosis	6.4e-05	0.000877	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL5—primary biliary cirrhosis	6.32e-05	0.000865	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NUP210—primary biliary cirrhosis	6.16e-05	0.000844	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.12e-05	0.000838	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ABCG2—primary biliary cirrhosis	5.73e-05	0.000784	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LBR—primary biliary cirrhosis	5.65e-05	0.000774	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	5.41e-05	0.000741	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.3e-05	0.000726	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AGT—primary biliary cirrhosis	5.29e-05	0.000723	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL10—primary biliary cirrhosis	5.25e-05	0.000719	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	5.02e-05	0.000688	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CTGF—primary biliary cirrhosis	4.92e-05	0.000673	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GOT2—primary biliary cirrhosis	4.87e-05	0.000667	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP3—primary biliary cirrhosis	4.79e-05	0.000656	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—TYK2—primary biliary cirrhosis	4.79e-05	0.000655	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CD80—primary biliary cirrhosis	4.68e-05	0.000641	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL5—primary biliary cirrhosis	4.52e-05	0.000619	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.38e-05	0.0006	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GOT1—primary biliary cirrhosis	4.21e-05	0.000576	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GGT1—primary biliary cirrhosis	4.21e-05	0.000576	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	4.09e-05	0.000559	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TYK2—primary biliary cirrhosis	3.95e-05	0.000541	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.8e-05	0.00052	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AGT—primary biliary cirrhosis	3.78e-05	0.000518	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARGC1A—primary biliary cirrhosis	3.74e-05	0.000512	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	3.73e-05	0.00051	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	3.69e-05	0.000504	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	3.64e-05	0.000498	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	3.42e-05	0.000469	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	3.42e-05	0.000469	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CD80—primary biliary cirrhosis	3.35e-05	0.000459	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	3.15e-05	0.000432	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—primary biliary cirrhosis	3.11e-05	0.000426	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.08e-05	0.000422	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AGT—primary biliary cirrhosis	2.92e-05	0.000399	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TYK2—primary biliary cirrhosis	2.83e-05	0.000387	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.81e-05	0.000384	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	2.69e-05	0.000369	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	2.4e-05	0.000329	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	2.26e-05	0.000309	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	2.26e-05	0.000309	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—primary biliary cirrhosis	2.24e-05	0.000306	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—primary biliary cirrhosis	2.23e-05	0.000305	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.2e-05	0.000302	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	2.19e-05	0.000299	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	2.06e-05	0.000282	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	1.91e-05	0.000262	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.68e-05	0.00023	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	1.64e-05	0.000225	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	1.63e-05	0.000223	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	1.4e-05	0.000192	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	1.4e-05	0.000192	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	1.36e-05	0.000186	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	1.26e-05	0.000173	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	1.25e-05	0.000171	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	1.08e-05	0.000148	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	1.07e-05	0.000147	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	9.73e-06	0.000133	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	9.26e-06	0.000127	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	9.26e-06	0.000127	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	8.24e-06	0.000113	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	7.47e-06	0.000102	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	6.42e-06	8.79e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	4.93e-06	6.74e-05	CbGpPWpGaD
